Live Breaking News & Updates on Market Prospects

Stay updated with breaking news from Market prospects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Capricor Advances in DMD Therapy With Positive Study Data - Hims & Hers Health (NYSE:HIMS), Capricor Therapeutics (NASDAQ:CAPR)

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology firm focused on innovative therapies for rare diseases, has announced favorable three-year results from the ongoing HOPE-2 open-label extension (OLE) study on CAP-1002 for Duchenne muscular dystrophy. ....

United States , Cincinnati Children Hospital Medical Center , Hims Hers Health , Cincinnati Children , Hospital Medical Center , Biologics License Application , Market Prospects , Mordor Intelligence , Zacks Rank , Hers Health , Strong Buy , Hers Heath ,